Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

GLP-1 drugs linked to reduced risk of epilepsy

Written by | 14 Dec 2025

A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy. The findings appeared… read more.

Lundbeck to present eight new analyses on bexicaserin at AES 2025, reinforcing sustained seizure-reduction potential across DEEs

Written by | 6 Dec 2025

Lundbeck A/S (Lundbeck) announced that new pipeline data regarding bexicaserin (LP352), a novel investigational drug for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs), will… read more.

New clinical trial to advance seizure monitoring and improve epilepsy diagnosis

Written by | 28 Oct 2025

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and… read more.

Use of antiseizure drugs with known or uncertain risks during pregnancy continues

Written by | 28 Jul 2025

Despite evidence of the risk of malformations at birth, or birth defects, use of some antiseizure drugs during pregnancy has persisted, according to a study published on July… read more.

Epilepsy in dogs: New advances for diagnosis and research

Written by | 28 Jun 2025

An international research team from the fields of veterinary medicine and genetics has developed a new survey tool to advance canine epilepsy diagnosis and research. Epilepsy and dyskinesia… read more.

NICE (UK) recommends Ontozry (cenobamate) for treating focal onset seizures in epilepsy – Arvelle Therapeutics

Written by | 13 Jun 2025

NICE(UK): Cenobamate is recommended as an option as an add-on treatment for focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has… read more.

Common genetic variants linked to drug-resistant epilepsy

Written by | 22 Apr 2025

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study led by researchers at UCL and UTHealth… read more.

New research offers hope for preventing epilepsy after traumatic brain injury

Written by | 28 Jan 2025

A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can develop following traumatic brain injury. Led by researchers at FutureNeuro, the… read more.

Newer epilepsy medications used during pregnancy do not affect neurological development in children

Written by | 4 Dec 2024

Children of mothers who took certain antiseizure medications while pregnant do not have worse neurodevelopmental outcomes at age 6, according to a long-running study funded by the National… read more.

UCB to accelerate innovation and strategic partnerships, divesting mature product portfolio in China to CBC Group.

Written by | 2 Sep 2024

UCB, a global biopharmaceutical company, announced a strategic divestment deal in China, underscoring its strategic shift towards innovation and partnership in one of the world’s fastest-growing pharmaceutical markets…. read more.

Antiseizure medications can produce life-threatening reactions

Written by | 24 Jun 2024

Targeted blood tests, asking patients about risk factors, and dose modifications can lessen the risk of potentially fatal reactions to antiseizure medications that millions of Americans take for… read more.

Global experts release new guidelines on prevention of progression of epileptic seizures, addressing critical treatment gaps – UCB

Written by | 17 Jun 2024

New recommendations released in Epileptic Disorders by a global expert group comprising epileptologists, neurologists and pharmacologists from Europe and North America address the critical unmet needs associated with… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.